Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Operating Expenses (2018 - 2025)

Historic Operating Expenses for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $23.8 million.

  • Neurogene's Operating Expenses rose 729.49% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.3 million, marking a year-over-year increase of 2678.66%. This contributed to the annual value of $83.5 million for FY2024, which is 5027.98% up from last year.
  • Latest data reveals that Neurogene reported Operating Expenses of $23.8 million as of Q3 2025, which was up 729.49% from $26.1 million recorded in Q2 2025.
  • Neurogene's 5-year Operating Expenses high stood at $26.1 million for Q2 2025, and its period low was $12.6 million during Q2 2023.
  • For the 3-year period, Neurogene's Operating Expenses averaged around $19.5 million, with its median value being $21.1 million (2024).
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 6718.8% in 2024, then skyrocketed by 729.49% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Operating Expenses stood at $14.7 million in 2023, then soared by 46.01% to $21.5 million in 2024, then grew by 10.63% to $23.8 million in 2025.
  • Its Operating Expenses was $23.8 million in Q3 2025, compared to $26.1 million in Q2 2025 and $25.9 million in Q1 2025.